questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Génome microbien
Génome viral
Génome viral : Questions médicales fréquentes
Termes MeSH sélectionnés :
Combined Modality Therapy
Diagnostic
5
Tests sérologiques
Tests moléculaires
Séquencement
Génome viral
Symptômes
Infection virale
Classification des virus
Acides nucléiques
Symptômes
5
Symptômes
Infection virale
Variabilité des symptômes
Virus
Évolution des symptômes
Réponse immunitaire
Asymptomatique
Infection virale
Prévention
5
Vaccins
Efficacité des vaccins
Santé publique
Surveillance épidémiologique
Masques
Transmission virale
Voyages
Propagation virale
Traitements
5
Antibiotiques
Infections virales
Antiviraux
Réplication virale
Traitements spécifiques
Virus
Vaccins
Prévention des infections
Complications
5
Complications
Infection virale
Traitement des complications
Soins de soutien
Fréquence des complications
État de santé
Personnes âgées
Risque de complications
Prévention des complications
Diagnostic précoce
Facteurs de risque
5
Facteurs de risque
Immunodépression
Mode de vie
Prévention des infections
Maladies chroniques
Système immunitaire
Voyages
Risque d'infection
Contacts étroits
Transmission virale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Génome viral : Questions médicales les plus fréquentes",
"headline": "Génome viral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Génome viral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Génome viral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Génome microbien",
"url": "https://questionsmedicales.fr/mesh/D064349",
"about": {
"@type": "MedicalCondition",
"name": "Génome microbien",
"code": {
"@type": "MedicalCode",
"code": "D064349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes viraux",
"alternateName": "Genes, Viral",
"url": "https://questionsmedicales.fr/mesh/D005814",
"about": {
"@type": "MedicalCondition",
"name": "Gènes viraux",
"code": {
"@type": "MedicalCode",
"code": "D005814",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes env",
"alternateName": "Genes, env",
"url": "https://questionsmedicales.fr/mesh/D015752",
"about": {
"@type": "MedicalCondition",
"name": "Gènes env",
"code": {
"@type": "MedicalCode",
"code": "D015752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.172"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes gag",
"alternateName": "Genes, gag",
"url": "https://questionsmedicales.fr/mesh/D015750",
"about": {
"@type": "MedicalCondition",
"name": "Gènes gag",
"code": {
"@type": "MedicalCode",
"code": "D015750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.258"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes précoces",
"alternateName": "Genes, Immediate-Early",
"url": "https://questionsmedicales.fr/mesh/D017781",
"about": {
"@type": "MedicalCondition",
"name": "Gènes précoces",
"code": {
"@type": "MedicalCode",
"code": "D017781",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.345"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes de particule intracisternale de type A",
"alternateName": "Genes, Intracisternal A-Particle",
"url": "https://questionsmedicales.fr/mesh/D007426",
"about": {
"@type": "MedicalCondition",
"name": "Gènes de particule intracisternale de type A",
"code": {
"@type": "MedicalCode",
"code": "D007426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes nef",
"alternateName": "Genes, nef",
"url": "https://questionsmedicales.fr/mesh/D015754",
"about": {
"@type": "MedicalCondition",
"name": "Gènes nef",
"code": {
"@type": "MedicalCode",
"code": "D015754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pol",
"alternateName": "Genes, pol",
"url": "https://questionsmedicales.fr/mesh/D015751",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pol",
"code": {
"@type": "MedicalCode",
"code": "D015751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.667"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes pX",
"alternateName": "Genes, pX",
"url": "https://questionsmedicales.fr/mesh/D016355",
"about": {
"@type": "MedicalCondition",
"name": "Gènes pX",
"code": {
"@type": "MedicalCode",
"code": "D016355",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes rev",
"alternateName": "Genes, rev",
"url": "https://questionsmedicales.fr/mesh/D015757",
"about": {
"@type": "MedicalCondition",
"name": "Gènes rev",
"code": {
"@type": "MedicalCode",
"code": "D015757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes tat",
"alternateName": "Genes, tat",
"url": "https://questionsmedicales.fr/mesh/D015756",
"about": {
"@type": "MedicalCondition",
"name": "Gènes tat",
"code": {
"@type": "MedicalCode",
"code": "D015756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vif",
"alternateName": "Genes, vif",
"url": "https://questionsmedicales.fr/mesh/D016341",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vif",
"code": {
"@type": "MedicalCode",
"code": "D016341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.890"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpr",
"alternateName": "Genes, vpr",
"url": "https://questionsmedicales.fr/mesh/D016334",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpr",
"code": {
"@type": "MedicalCode",
"code": "D016334",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.897"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes vpu",
"alternateName": "Genes, vpu",
"url": "https://questionsmedicales.fr/mesh/D016338",
"about": {
"@type": "MedicalCondition",
"name": "Gènes vpu",
"code": {
"@type": "MedicalCode",
"code": "D016338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.358.840.500.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Génome viral",
"alternateName": "Genome, Viral",
"code": {
"@type": "MedicalCode",
"code": "D016679",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kiramage Chathuranga",
"url": "https://questionsmedicales.fr/author/Kiramage%20Chathuranga",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea."
}
},
{
"@type": "Person",
"name": "Jong-Soo Lee",
"url": "https://questionsmedicales.fr/author/Jong-Soo%20Lee",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Alfred A Antson",
"url": "https://questionsmedicales.fr/author/Alfred%20A%20Antson",
"affiliation": {
"@type": "Organization",
"name": "York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk."
}
},
{
"@type": "Person",
"name": "Stephen S-T Yau",
"url": "https://questionsmedicales.fr/author/Stephen%20S-T%20Yau",
"affiliation": {
"@type": "Organization",
"name": "Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Anouk Willemsen",
"url": "https://questionsmedicales.fr/author/Anouk%20Willemsen",
"affiliation": {
"@type": "Organization",
"name": "Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy.",
"datePublished": "2023-08-06",
"url": "https://questionsmedicales.fr/article/37586927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clcc.2023.08.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses.",
"datePublished": "2022-11-09",
"url": "https://questionsmedicales.fr/article/36351568",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1759-7714.14724"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma.",
"datePublished": "2022-07-17",
"url": "https://questionsmedicales.fr/article/35963771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clml.2022.07.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36102865",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DCR.0000000000002600"
}
},
{
"@type": "ScholarlyArticle",
"name": "PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK).",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36099671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejca.2022.07.027"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Génome microbien",
"item": "https://questionsmedicales.fr/mesh/D064349"
},
{
"@type": "ListItem",
"position": 6,
"name": "Génome viral",
"item": "https://questionsmedicales.fr/mesh/D016679"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Génome viral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Génome viral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Génome viral",
"description": "Comment détecte-t-on un génome viral ?\nQuels tests sont utilisés pour le génome viral ?\nPeut-on séquencer un génome viral ?\nQuels symptômes indiquent une infection virale ?\nComment différencier les virus par leur génome ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Génome viral",
"description": "Quels sont les symptômes d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nComment les symptômes évoluent-ils ?\nLes symptômes sont-ils toujours présents ?\nQuels symptômes indiquent une complication ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Génome viral",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures de santé publique aident à prévenir les épidémies ?\nLe port de masque aide-t-il à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Génome viral",
"description": "Quels traitements existent pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements varient-ils selon le virus ?\nLes vaccins préviennent-ils toutes les infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Génome viral",
"description": "Quelles sont les complications possibles d'une infection virale ?\nComment les complications sont-elles traitées ?\nLes complications sont-elles fréquentes ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Génome viral",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts fréquents avec des malades augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Combined+Modality+Therapy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on un génome viral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des techniques comme la PCR pour identifier le matériel génétique viral."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le génome viral ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et les tests moléculaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on séquencer un génome viral ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le séquençage permet d'analyser la structure du génome viral."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires peuvent signaler une infection virale."
}
},
{
"@type": "Question",
"name": "Comment différencier les virus par leur génome ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du type d'acide nucléique (ADN ou ARN) aide à classer les virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, fatigue, et parfois éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virus peuvent être asymptomatiques chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une complication ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés respiratoires ou des douleurs thoraciques peuvent signaler des complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et n'offre pas une protection universelle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de santé publique aident à prévenir les épidémies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance épidémiologique et la vaccination de masse sont cruciales."
}
},
{
"@type": "Question",
"name": "Le port de masque aide-t-il à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masque réduit la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent faciliter la propagation des virus d'une région à une autre."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les traitements symptomatiques et les vaccins sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou bloquent l'entrée du virus dans les cellules."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Les vaccins préviennent-ils toutes les infections virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ne couvrent pas tous les virus, mais protègent contre certains."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure pneumonie, encéphalite ou défaillance organique."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, souvent avec des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend du virus et de l'état de santé de l'individu, certaines infections sont plus risquées."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves lors d'infections virales."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et l'exposition à des personnes infectées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir le système immunitaire et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte incidence de virus peut accroître le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les contacts fréquents avec des malades augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, être en contact étroit avec des personnes infectées augmente le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2025
Contenu vérifié selon les dernières recommandations médicales
└─
Gènes viraux
Genes, Viral
D005814
-
G05.360.340.358.840.500
└─└─
Gènes env
Genes, env
D015752
-
G05.360.340.358.840.500.172
└─└─
Gènes gag
Genes, gag
D015750
-
G05.360.340.358.840.500.258
└─└─
Gènes précoces
Genes, Immediate-Early
D017781
-
G05.360.340.358.840.500.345
└─└─
Gènes de particule intracisternale de type A
Genes, Intracisternal A-Particle
D007426
-
G05.360.340.358.840.500.360
└─└─
Gènes nef
Genes, nef
D015754
-
G05.360.340.358.840.500.600
└─└─
Gènes pol
Genes, pol
D015751
-
G05.360.340.358.840.500.667
└─└─
Gènes pX
Genes, pX
D016355
-
G05.360.340.358.840.500.735
└─└─
Gènes rev
Genes, rev
D015757
-
G05.360.340.358.840.500.775
└─└─
Gènes tat
Genes, tat
D015756
-
G05.360.340.358.840.500.850
└─└─
Gènes vif
Genes, vif
D016341
-
G05.360.340.358.840.500.890
└─└─
Gènes vpr
Genes, vpr
D016334
-
G05.360.340.358.840.500.897
└─└─
Gènes vpu
Genes, vpu
D016338
-
G05.360.340.358.840.500.900
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk.
Structural Biology, The Francis Crick Institute, London, UK. fred.antson@york.ac.uk.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China.
Beijing Institute of Mathematical Sciences and Applications (Bimsa), Beijing, 101408, People's Republic of China.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Netherlands Institute of Ecology (NIOO-KNAW), Postbus 50, 6700 AB, Wageningen, The Netherlands.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, United States. Electronic address: carlos.catalano@cuanschutz.edu.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Sealy Center for Structural and Molecular Biophysics, University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Grambling State University, Grambling, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Grambling State University, Grambling, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
School of Biological Sciences, Louisiana Tech University, Ruston, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Physics and Chemistry Programs, Louisiana Tech University, Ruston, LA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer University School of Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Mercer Medicine, Macon, GA.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Jackson State University, Jackson, MS.
Publications dans "Génome viral" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Jackson State University, Jackson, MS.
Publications dans "Génome viral" :
Survival rates in early-stage rectal cancer patients have increased over the past few decades. Societies such as the National Comprehensive Cancer Network (NCCN), American Cancer Society (ACS), Americ...
We aimed to analyze the radiation dose and compare survival among combined modality therapy using modern radiation techniques for patients with esophageal squamous cell carcinoma (ESCC)....
This retrospective study included patients with clinically staged T1-4N0-3M0 ESCC from 2014 to 2018. Patients who received combined modality therapies with curative intent were enrolled. The overall s...
Of the 259 patients, 141 (54.4%) received definitive concurrent chemoradiotherapy (DCCRT); 67 (25.9%) underwent neoadjuvant chemoradiotherapy followed by surgery (NCRT+S); 51 (19.7%) obtained surgery ...
Our results suggest that NCRT+S can provide a favorable survival for patients with ESCC, especially in patients who achieved pCR. The optimal radiation dose might be 55-60 Gy for patients receiving DC...
The standard of care for early-stage Hodgkin Lymphoma (HL) is combined modality therapy (CMT) consisting of chemotherapy and involved site radiation therapy (ISRT). Recent treatment de-escalation tria...
This study used a cost-effectiveness Markov model simulating 5 year outcomes for 1 million patients with early-stage HL treated with either PET-directed therapy consisting of 2 cycles of ABVD chemothe...
We found that PET-directed therapy and CMT strategies were associated with costs of $47,362 and $41,167, respectively. The CMT strategy was equally as effective as the PET-directed therapy strategy wi...
For patients with early-stage HL, CMT is the cost-effective strategy as compared with PET-directed therapy....
There is limited knowledge on long-term bowel, sexual, and urinary function after combined modality therapy for anal squamous-cell cancer....
This study aimed to evaluate long-term changes in patients treated with combined modality....
This was a retrospective study of prospectively collected patient-reported outcome surveys....
This study was conducted at a single institution....
There were 143 patients with stage I to III anal cancer who were treated with chemoradiation and had completed the survey....
This study included patient-reported outcomes reflecting bowel, sexual, and urinary function....
Thirty-nine percent of patients had major low anterior resection syndrome at baseline. Major low anterior resection syndrome remained stable (38%; 95% CI, 31%-46%) with no change over time (OR 0.95; 9...
This was a single-institution study and only patients who answered the questionnaire were included in the study....
A significant proportion of patients have major low anterior resection syndrome at baseline and after successful treatment for anal cancer. Having major low anterior resection syndrome at baseline was...
ANTECEDENTES:Existe un conocimiento limitado sobre la función intestinal, sexual y urinaria a largo plazo después de la terapia de modalidad combinada para el cáncer anal de células escamosas.OBJETIVO...
Positron emission tomography (PET) may differentiate responding and non-responding tumours early in the treatment of locally advanced gastroesophageal junction adenocarcinomas. Early PET non-responder...
Patients underwent baseline...
In total, 160 patients with resectable gastroesophageal junction adenocarcinomas were prospectively investigated by PET scanning. Eighty-five patients (53%) were excluded. Seventy-five eligible patien...
The primary endpoint of the study to increase the R0 resection rate in metabolic NR was not met. PET response after induction CTX is prognostic for outcome with a prolonged OS and DFS in PET responder...
NCT00002014-000860-16....
Facial aging involves multilevel changes, extending from the skin to deep support structures. A comprehensive treatment approach targeting the many aspects of facial dynamics and architecture is often...
To explore the integration of botulinum toxin type A (BoNT-A) into multimodal aesthetic treatment plans....
This article reviews evidence supporting the combination of BoNT-A with other minimally invasive cosmetic therapies, including dermal fillers, lasers, and energy-based devices as well as with plastic ...
Combination treatment protocols including BoNT-A demonstrate higher patient satisfaction and retention rates compared to monotherapy or sequential treatments. Some guidelines for sequencing of treatme...
Integrating BoNT-A into a larger aesthetic treatment plan is crucial for achieving natural and satisfying results in facial rejuvenation. Evidence supports better outcomes when incorporating with both...
Gastrointestinal cancers represent a major challenge to public health. Pancreatic cancer is the most lethal cancer among all gastrointestinal cancers. Most patients cannot meet the criteria of resecti...
Neoadjuvant chemotherapy helps some patients regain the opportunity of radical resection. An optimal regimen of chemotherapy is one that maximizes the anti-tumor efficacy while maintaining a relativel...
Combination therapies in a multidisciplinary manner that involves modified chemotherapy regimen, radical resection, and intestine auto-transplantation may provide the currently best possible care to p...
Loop diuretics are the cornerstone of the treatment of volume overload in decompensated heart failure. However, often complete decongestion cannot be achieved rapidly with loop diuretics alone, partly...
Immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy have limited efficacy in treating advanced hepatocellular carcinoma (HCC). The synergistic effect of systemic therapy and radia...
This retrospective observational study analyzed the medical records of 194 patients with Barcelona Clinic Liver Cancer stage C HCC who were admitted to our center from August 2018 to June 2022 and rec...
A total of 76 patients diagnosed with advanced-stage HCC and treated with ICIs and antiangiogenic therapy were included in the study, with 33 patients in the RT group and 43 patients in the non-RT gro...
In comparison to the combination of ICIs and antiangiogenic therapy, the inclusion of RT has been observed to improve the DCR and survival outcomes in patients with advanced-stage HCC. The safety prof...
Patterned hair loss is a common type of non-scarring alopecia, characterized by miniaturization of hair follicles. The etiology of female pattern hair loss (FPHL) is not clearly linked to androgens or...